Navina Raises $55M Series C to Expand AI Clinical Intelligence Platform Across U.S.
Navina’s platform empowers healthcare providers to deliver high-quality, value-based care by putting powerful clinical insights at their fingertips
Company Name: Navina
Location: New York, NY
Industry: Health Tech
Funding Details:
- Amount: $55M (Series C)
- Total Funding to Date: $100M
- Investors:
- Lead: Growth Equity at Goldman Sachs Alternatives
- Participants: Vertex Ventures Israel, Grove Ventures, ALIVE
Purpose of Investment:
- Accelerate U.S. market expansion
- Enhance proprietary AI technology
- Improve patient outcomes through proactive clinical intelligence
Leadership:
- Co-Founders: Ronen Lavi, Shay Perera
Product:
Navina is an AI copilot that equips clinicians with real-time clinical intelligence, transforming scattered patient data into a unified, actionable profile. By integrating across care teams and touchpoints, Navina enables better diagnosis accuracy, improved quality metrics, and reduced administrative burden.
About Company:
Navina’s platform empowers healthcare providers to deliver high-quality, value-based care by putting powerful clinical insights at their fingertips. Already adopted by leading organizations like Privia Health, agilon health, and Millennium Physician Group, Navina is setting a new standard for AI in outpatient care.
